Monahan Joseph

CIK 00018617901 companyWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001861790

Recent Transactions

50 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01+10,925→ 292,920 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-03-01−50,000→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01$1.99/sh−27,258→ 265,662 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-03-01−10,925→ 10,925 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01+50,000→ 281,995 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-03+83,900→ 83,900 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2025-02-03+293,500→ 293,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−7,500→ 15,000 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01$2.48/sh−11,317→ 231,995 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+14,750→ 243,312 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+7,500→ 228,562 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−14,750→ 44,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02+52,667→ 52,667 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02−8,914→ 221,062 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02+17,380→ 229,976 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02−17,380→ 35,287 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-12-31−73,750→ 73,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31+73,750→ 245,533 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31−32,937→ 212,596 total
Gift
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-10−15,000→ 171,783 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-02+12,500→ 190,314 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-02$1.24/sh−3,531→ 186,783 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-02−12,500→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01+10,925→ 180,997 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01$1.24/sh−3,183→ 177,814 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-01−50,000→ 50,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-01−10,925→ 21,850 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01+50,000→ 184,641 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01$1.24/sh−14,569→ 170,072 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Unit
2024-02-01−7,500→ 22,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2024-02-01+206,500→ 206,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+59,000→ 59,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+147,500→ 147,500 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01$1.20/sh−2,583→ 134,641 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01+7,500→ 137,224 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-10-23$5.08/sh−6,000→ 129,724 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-08-21$7.32/sh−6,000→ 135,724 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-20$10.28/sh−6,000→ 141,724 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-03$12.63/sh−16,037→ 147,724 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-02+12,500→ 163,761 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-02$12.37/sh−14,800→ 151,261 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-03-02−12,500→ 12,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-01+50,000→ 155,136 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-01+13,750→ 105,136 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-03-01+10,925→ 166,061 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-03-01−13,750→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-03-01−10,925→ 32,775 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-03-01−50,000→ 100,000 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-02-15$13.06/sh−5,000→ 91,386 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2023-02-01+105,000→ 105,000 total

Companies

Aclaris Therapeutics, Inc.
Chief Scientific Officer
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103

WAYNE, PA, 19087

View on SEC.gov